PTCA and CABG   
Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
JACC Cardiovasc Interv, 2010. 3(3): p. 343-51.
R. C. Welsh, et al.,
Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial
J Am Coll Cardiol, 2010. 55(5): p. 432-40.
A. Kapur, et al.,
Requirement for emergent coronary artery bypass surgery following percutaneous coronary intervention in the stent era
Am J Cardiol, 2009. 103(7): p. 950-3.
P. Roy, et al.,
Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D)
Am J Cardiol, 2009. 103(5): p. 632-8.
L. Schwartz, et al.,
Percutaneous versus surgical revascularization for multivessel coronary artery disease: a single center 10 year follow-up of SOS trial patients
Catheter Cardiovasc Interv, 2009. 74(3): p. 420-6.
P. Buszman, et al.,
PCI versus CABG for multivessel coronary disease in diabetics
Catheter Cardiovasc Interv, 2009. 73(1): p. 50-8.
G. Tarantini, et al.,
The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction
Circulation, 2009. 120(25): p. 2529-40.
B. R. Chaitman, et al.,
Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial
Circulation, 2009. 120(25): p. 2550-8.
M. A. Hlatky, et al.,
Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution
Circulation, 2009. 119(15): p. 2040-50.
Y. Li, et al.,
Improving long-term outcomes following coronary artery bypass graft or percutaneous coronary revascularisation: results from a large, population-based cohort with first intervention 1995-2004
Heart, 2009. 95(4): p. 304-11.
H. M. Blackledge and I. B. Squire,
Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (ARTS-II)
Heart, 2009. 95(13): p. 1061-6.
N. Kukreja, et al.,
Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room
J Am Coll Cardiol, 2009. 53(3): p. 232-41.
D. X. Zhao, et al.,
Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials
Lancet, 2009. 373(9670): p. 1190-7.
M. A. Hlatky, et al.,
A randomized trial of therapies for type 2 diabetes and coronary artery disease
N Engl J Med, 2009. 360(24): p. 2503-15.
R. L. Frye, et al.,
CABG vs. stenting--clinical implications of the SYNTAX trial
N Engl J Med, 2009. 360(8): p. e10.
T. H. Lee, L. D. Hillis and E. G. Nabel,
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease
N Engl J Med, 2009. 360(10): p. 961-72.
P. W. Serruys, et al.,